Steven Kornfeld serves as Executive at Forte Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Steven Kornfeld has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 31, 2023 involved receiving (via award) 99,009 shares valued at $100.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 31, 2023 | FBRX | $100.0K | Award | 99,009 | $1.01 | Discretionary |
Steven Kornfeld currently holds 99,009 shares of Forte Biosciences, Inc. (FBRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Kornfeld has been a net neutral trader of FBRX stock. They have purchased $0 and sold $0 worth of shares.
Steven Kornfeld's most recent insider trade was on Jul 31, 2023, when they sold 99,009 shares at $1.01 per share.
Get notified when new Form 4 filings are submitted